GLP-1 Weight Loss Drugs: Benefits, Risks, and the Danger of Inappropriate Use
As the therapeutic landscape for obesity shifts, public health experts and regulatory bodies are raising alarms regarding the inappropriate use of glucagon-like peptide-1 receptor agonists. Recent clinical reports highlight severe ... Read More